Salameh Khalil Mohd, Anvar Paraparambil Vellamgot, Sarfrazul Abedin, Lina Hussain Habboub, Sajid Thyvilayil Salim, Samer Mahmoud Alhoyed
Department of Pediatrics and Neonatology, Al Wakra Hospital, Hamad Medical Corporation, Al Wakra, Qatar.
Int J Womens Health. 2020 Feb 4;12:59-70. doi: 10.2147/IJWH.S228738. eCollection 2020.
Epidural Analgesia (EA) is the most effective and most commonly used method for pain relief during labor. Some researchers have observed an association between EA and increased neonatal morbidity. But this observation was not consistent in many other studies.
The primary objective of the study was to examine whether exposure to epidural analgesia increased the risk of NICU admission. The secondary objectives included the risks of clinical chorioamnionitis, instrumental delivery, neonatal depression, respiratory distress, birth trauma, and neonatal seizure during the first 24 hours of life.
This was a retrospective cohort study involving 2360 low-risk nulliparous women who delivered at AWH, Qatar, during the two years between January 2016 December and 2017. Short-term neonatal outcomes of the mothers who received EA in active labor were compared with a similar population who did not receive EA. As secondary objectives, labor parameters like maternal temperature elevation, duration of the second stage of labor, and instrumental delivery were compared.
Significantly higher numbers of neonates were admitted to the NICU from the EA group (<0.001, OR 1.89, 95% CI 1.45 to 2.46). They were more likely to have respiratory distress (=0.01, OR 1.49, 95% CI 1.07 to 2.07), birth injuries (=0.02, OR =1.71, 95% CI 1.06 to 2.74), admission temperature>37.5 °C (0.04, OR 3.40, 95% CI 1.00 to 11.49), need for oxygen on the first day (=0.04, OR 1.44, 95% CI 1.01 to 2.07) and receive antibiotics (<0.001, OR 2.06,95% CI 1.47 to 2.79). There was no difference in the Apgar score at 1 minute (=0.12), need of resuscitation at birth (=0.05), neonatal white cell count (=0.34), platelet count (=0.38) and C reactive protein (=0.84). Mothers who received EA had a lengthier second stage (<0.001), temperature elevation >37.5°C (<0.001, OR 7.40, 95% CI 3.93 to 13.69) and instrumental delivery (<0.001, OR 2.13, 95% CI 1.69 to 2.68).
EA increases NICU admission, antibiotic exposure, neonatal birth injuries, need for positive pressure ventilation at birth, and respiratory distress in the first 24 hours of life. Mothers on epidural analgesia have prolonged second stage of labor, a higher rate of instrumental delivery, meconium-stained amniotic fluid, fetal distress, and temperature elevation.
硬膜外镇痛(EA)是分娩期间最有效且最常用的疼痛缓解方法。一些研究人员观察到EA与新生儿发病率增加之间存在关联。但这一观察结果在许多其他研究中并不一致。
该研究的主要目的是检查接受硬膜外镇痛是否会增加新生儿入住新生儿重症监护病房(NICU)的风险。次要目的包括临床绒毛膜羊膜炎、器械助产、新生儿抑郁、呼吸窘迫、出生创伤以及出生后24小时内新生儿惊厥的风险。
这是一项回顾性队列研究,涉及2016年1月至2017年12月期间在卡塔尔阿瓦医院分娩的2360名低风险初产妇。将活跃期分娩时接受EA的母亲的短期新生儿结局与未接受EA的类似人群进行比较。作为次要目的,比较了诸如产妇体温升高、第二产程持续时间和器械助产等分娩参数。
EA组中有显著更多的新生儿入住NICU(<0.001,比值比[OR]1.89,95%置信区间[CI]1.45至2.46)。他们更有可能出现呼吸窘迫(=0.01,OR 1.49,95%CI 1.07至2.07)、出生损伤(=0.02,OR =1.71,95%CI 1.06至2.74)、入院时体温>37.5°C(0.04,OR 3.40,95%CI 1.00至11.49)、出生第一天需要吸氧(=0.04,OR 1.44,95%CI 1.01至2.07)以及接受抗生素治疗(<0.001,OR 2.06,95%CI 1.47至2.79)。1分钟时的阿氏评分(=0.12)、出生时需要复苏(=0.05)、新生儿白细胞计数(=0.34)、血小板计数(=0.38)和C反应蛋白(=0.84)没有差异。接受EA的母亲第二产程更长(<0.001)、体温升高>37.5°C(<0.001,OR 7.40,95%CI 3.93至13.69)以及器械助产(<0.001,OR 2.13,95%CI 1.69至2.68)。
EA会增加新生儿入住NICU、抗生素暴露、新生儿出生损伤、出生时需要正压通气以及出生后24小时内呼吸窘迫的风险。接受硬膜外镇痛的母亲第二产程延长、器械助产率更高、羊水粪染、胎儿窘迫以及体温升高。